Reed Thomas D.

Chief Science Officer at PGEN

Sold, on record
$1.3M
Dollars the filings state
Form 4 sales
8
Latest Jan 6, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • PGENPRECIGEN, INC.Chief Science Officer

Sales by reason

0
Routine
6
Plan not stated
0
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Jan 6, 2020Plan not stated

    PGEN

    Sold 3.5% of their holdings

    $32k5,416 shares at $5.83

    Filed Jan 7, 2020Form 4

  2. Jan 3, 2020Plan not stated

    PGEN

    Sold 2.2% of their holdings

    $17k2,986 shares at $5.77

    Filed Jan 6, 2020Form 4

  3. Jan 2, 2020Plan not stated

    PGEN

    Sold 2.7% of their holdings

    $20k3,533 shares at $5.60

    Filed Jan 3, 2020Form 4

  4. Oct 1, 2019Plan not stated

    PGEN

    Sold 3% of their holdings

    $20k3,658 shares at $5.50

    Filed Oct 2, 2019Form 4

  5. Jul 1, 2019Plan not stated

    PGEN

    Sold 3.2% of their holdings

    $27k3,527 shares at $7.76

    Filed Jul 2, 2019Form 4

  6. Mar 5, 2019Unusual

    PGEN

    Sold 84.5% of their holdings

    $954k227,800 shares at $4.19

    Filed Mar 6, 2019Form 4

  7. Jan 3, 2019Plan not stated

    PGEN

    Sold 3.6% of their holdings

    $21k2,944 shares at $7.07

    Filed Jan 4, 2019Form 4

  8. Dec 31, 2018Unusual

    PGEN

    Sold 29.2% of their holdings

    $191k30,000 shares at $6.36

    Filed Jan 3, 2019Form 4

8 of 8

Every transaction

Every transaction on a Form 4 or Form 5 by Reed Thomas D.
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jan 6, 2020Jan 7, 2020PGENChief Science OfficerSold5,416$5.83$32k148,888SEC
Jan 4, 2020Jan 7, 2020PGENChief Science OfficerExercised or settledRestricted Stock Units18,94056,818SEC
Jan 4, 2020Jan 7, 2020PGENChief Science OfficerExercised options18,940154,304SEC
Jan 3, 2020Jan 6, 2020PGENChief Science OfficerSold2,986$5.77$17k135,364SEC
Jan 2, 2020Jan 6, 2020PGENChief Science OfficerExercised or settledRestricted Stock Units9,76619,531SEC
Jan 2, 2020Jan 6, 2020PGENChief Science OfficerExercised options9,766138,350SEC
Jan 2, 2020Jan 3, 2020PGENChief Science OfficerSold3,533$5.60$20k128,584SEC
Dec 31, 2019Jan 3, 2020PGENChief Science OfficerExercised or settledRestricted Stock Units14,34014,340SEC
Dec 31, 2019Jan 3, 2020PGENChief Science OfficerExercised options14,340132,117SEC
Oct 1, 2019Oct 2, 2019PGENChief Science OfficerSold3,658$5.50$20k117,777SEC
Sep 30, 2019Oct 2, 2019PGENChief Science OfficerExercised or settledRestricted Stock Units14,34128,680SEC
Sep 30, 2019Oct 2, 2019PGENChief Science OfficerExercised options14,341121,435SEC
Jul 1, 2019Jul 2, 2019PGENChief Science OfficerSold3,527$7.76$27k107,094SEC
Jun 30, 2019Jul 2, 2019PGENChief Science OfficerExercised or settledRestricted Stock Units14,34143,021SEC
Jun 30, 2019Jul 2, 2019PGENChief Science OfficerExercised options14,341110,621SEC
Apr 9, 2019Apr 11, 2019PGENChief Science OfficerAwardedRestricted Stock Units57,36257,362SEC
Mar 5, 2019Mar 6, 2019PGENChief Science OfficerSold227,800$4.19$954k41,705SEC
Feb 7, 2019Feb 11, 2019PGENChief Science OfficerExercised or settledOption to Purchase Common Stock (Right to Buy)2,9690SEC
Feb 7, 2019Feb 11, 2019PGENChief Science OfficerExercised options2,969$3.17$9k96,280SEC
Jan 4, 2019Jan 8, 2019PGENChief Science OfficerAwardedRestricted Stock Units75,75875,758SEC
Jan 4, 2019Jan 8, 2019PGENChief Science OfficerAwarded13,77493,311SEC
Jan 3, 2019Jan 4, 2019PGENChief Science OfficerSold2,944$7.07$21k79,537SEC
Jan 2, 2019Jan 4, 2019PGENChief Science OfficerExercised or settledRestricted Stock Units9,76629,297SEC
Jan 2, 2019Jan 4, 2019PGENChief Science OfficerExercised options9,76682,481SEC
Dec 31, 2018Jan 3, 2019PGENChief Science OfficerSold30,000$6.36$191k72,715SEC
Jan 2, 2018Jan 8, 2018PGENChief Science OfficerAwardedRestricted Stock Units39,06339,063SEC
Oct 16, 2017Oct 17, 2017PGENChief Science OfficerExercised or settledOption to Purchase Common Stock (Right to Buy)38,5980SEC
Oct 16, 2017Oct 17, 2017PGENChief Science OfficerExercised options38,598$2.64$102k102,715SEC
Feb 2, 2017Feb 6, 2017PGENChief Science OfficerAwardedOption to Purchase Common Stock (Right to Buy)100,000100,000SEC
Dec 3, 2015Dec 7, 2015PGENChief Science OfficerReturned to the companyOption to Purchase Common Stock (Right to Buy)64,1170SEC
Dec 3, 2015Dec 7, 2015PGENChief Science OfficerAwarded64,117$1.29$83k64,117SEC
May 13, 2014May 13, 2014PGENChief Science OfficerBought640$15.60$10k2,440SEC
Mar 20, 2014Mar 24, 2014PGENChief Science OfficerAwardedOption to Purchase Common Stock (Right to Buy)350,000350,000SEC
Aug 13, 2013Aug 15, 2013PGENChief Science OfficerBought1,800$16.00$29k1,800SEC
Aug 13, 2013Aug 15, 2013PGENChief Science OfficerConvertedSeries D Convertible Preferred Stock1,4800SEC
Aug 13, 2013Aug 15, 2013PGENChief Science OfficerConverted90079,340SEC

Sales and notices (8)

Form 144 notices and Form 4 sales by Reed Thomas D.
Source
Jan 6, 2020Jan 7, 2020PGENChief Science OfficerForm 4 sale5,416$32k3.5%Plan not statedSEC
Jan 3, 2020Jan 6, 2020PGENChief Science OfficerForm 4 sale2,986$17k2.2%Plan not statedSEC
Jan 2, 2020Jan 3, 2020PGENChief Science OfficerForm 4 sale3,533$20k2.7%Plan not statedSEC
Oct 1, 2019Oct 2, 2019PGENChief Science OfficerForm 4 sale3,658$20k3.0%Plan not statedSEC
Jul 1, 2019Jul 2, 2019PGENChief Science OfficerForm 4 sale3,527$27k3.2%Plan not statedSEC
Mar 5, 2019Mar 6, 2019PGENChief Science OfficerForm 4 sale227,800$954k84.5%UnusualSEC
Jan 3, 2019Jan 4, 2019PGENChief Science OfficerForm 4 sale2,944$21k3.6%Plan not statedSEC
Dec 31, 2018Jan 3, 2019PGENChief Science OfficerForm 4 sale30,000$191k29.2%UnusualSEC